Shares of Cryoport, Inc. (CYRX) have traded between $8.44 – 25.03. The next earnings date is set for Mar 05, 2020. Let’s see how its prospects are shaping up.

What does Cryoport, Inc.(CYRX) do?

CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Irvine, CA.

CYRX Insider Trading Insight

On 2019-11-21, Stefanovich Robert CFO sold 135,036 shares of CYRX. That represents a value of $1,000. Not to be outdone, on 2019-11-19, Berman Richard J S – Sale+OE sold5,000 shares of CYRX. These insiders are clearly in the know because they work closely with the company.

The LOPE Consensus Price Target

The mean recommendation of Grand Canyon Education, Inc. from top Wall Street analysts is a Strong Buy. That is based on 3 analysts who work on the Street. Based on 3 analysts offering 12 month price targets for Grand Canyon Education in the last 3 months. The average price target is $119.67 with a high forecast of $125.00 and a low forecast of $116.00. The average price target represents a 27.40% increase from the last price of $93.93. Last week, several articles were published in financial papers about LOPE and 37% Bearish while 63% Bullish.

LOPE Intraday Trading

LOPE is due to report earnings on Feb 19, 2020. In the last year the price has ranged from 76.49 – 132.73. Recently, Keegan Lisa Graham purchased 100 shares of LOPE. He is a $528,780 shareholder in LOPE.

Looking for stocks similar to CYRX and LOPE?

Here are some stocks to consider: